📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents. (2018)

First Author: Rajoli RKR
Attributed to:  Non-Attrition HAART nanoparticle therapies for HIV/AIDS Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40262-017-0557-x

PubMed Identifier: 28540638

Publication URI: http://europepmc.org/abstract/MED/28540638

Type: Journal Article/Review

Volume: 57

Parent Publication: Clinical pharmacokinetics

Issue: 2

ISSN: 0312-5963